MX361964B - Inhibición del crecimiento microbiano por inhibición de aconitasa. - Google Patents
Inhibición del crecimiento microbiano por inhibición de aconitasa.Info
- Publication number
- MX361964B MX361964B MX2013004556A MX2013004556A MX361964B MX 361964 B MX361964 B MX 361964B MX 2013004556 A MX2013004556 A MX 2013004556A MX 2013004556 A MX2013004556 A MX 2013004556A MX 361964 B MX361964 B MX 361964B
- Authority
- MX
- Mexico
- Prior art keywords
- inhibition
- aconitase
- microbial growth
- activity
- fungal cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a un método para inhibir la actividad de aconitasa de células fúngicas en un individuo, el método comprende administrar un inhibidor de la actividad de aconitasa a la célula fúngica en una cantidad eficaz para inhibir la actividad de aconitasa mediante dichas células fúngicas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40775710P | 2010-10-28 | 2010-10-28 | |
PCT/US2011/058269 WO2012058526A1 (en) | 2010-10-28 | 2011-10-28 | Inhibition of microbial growth by aconitase inhibition |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013004556A MX2013004556A (es) | 2013-06-07 |
MX361964B true MX361964B (es) | 2018-12-19 |
Family
ID=44947235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013004556A MX361964B (es) | 2010-10-28 | 2011-10-28 | Inhibición del crecimiento microbiano por inhibición de aconitasa. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2632552B1 (es) |
JP (2) | JP2013543847A (es) |
CN (2) | CN105168225A (es) |
BR (1) | BR112013008578B1 (es) |
MX (1) | MX361964B (es) |
WO (1) | WO2012058526A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018012704A (es) * | 2016-04-29 | 2019-02-11 | Procter & Gamble | Metodo para tratar un trastorno del cabello con n-hidroxipiridinonas. |
JP6988185B2 (ja) * | 2017-06-16 | 2022-01-05 | 住友ベークライト株式会社 | 防カビ剤、防カビ樹脂フィルム、防カビ積層フィルム及び防カビ包装体 |
EP4076489A1 (en) * | 2019-12-20 | 2022-10-26 | Linnane Pharma AB | Lon protease, alpha-hemolysin, ck1-alpha-1; c-myb inhibitor or a cebp-delta inhibitor as therapeutics |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2666058A (en) * | 1950-05-16 | 1954-01-12 | Ciba Pharm Prod Inc | Undecylenic acid esters of 8-hydroxyquinolines |
US2809971A (en) | 1955-11-22 | 1957-10-15 | Olin Mathieson | Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same |
US3236733A (en) | 1963-09-05 | 1966-02-22 | Vanderbilt Co R T | Method of combatting dandruff with pyridinethiones metal salts detergent compositions |
US3761418A (en) | 1967-09-27 | 1973-09-25 | Procter & Gamble | Detergent compositions containing particle deposition enhancing agents |
US3753196A (en) | 1971-10-05 | 1973-08-14 | Kulite Semiconductor Products | Transducers employing integral protective coatings and supports |
US4345080A (en) | 1980-02-07 | 1982-08-17 | The Procter & Gamble Company | Pyridinethione salts and hair care compositions |
US4323683A (en) | 1980-02-07 | 1982-04-06 | The Procter & Gamble Company | Process for making pyridinethione salts |
US4379753A (en) | 1980-02-07 | 1983-04-12 | The Procter & Gamble Company | Hair care compositions |
US4470982A (en) | 1980-12-22 | 1984-09-11 | The Procter & Gamble Company | Shampoo compositions |
ATE176396T1 (de) * | 1987-10-22 | 1999-02-15 | Procter & Gamble | Chelatbildner enthaltende lichtschutzmittel |
JPH0623087B2 (ja) * | 1989-10-09 | 1994-03-30 | 花王株式会社 | 洗浄剤組成物 |
GB9607568D0 (en) * | 1996-04-12 | 1996-06-12 | Unilever Plc | Antimicrobial hair treatment composition |
US6017936A (en) * | 1997-03-14 | 2000-01-25 | Arch Chemicals, Inc. | Method for producing particles of pyrithione salts and particles so produced |
CA2376803C (en) * | 1999-06-25 | 2008-08-19 | The Procter & Gamble Company | Topical anti-microbial compositions |
JP2002363077A (ja) * | 2001-06-01 | 2002-12-18 | Lion Corp | 口腔用組成物 |
JP2005526111A (ja) * | 2002-04-22 | 2005-09-02 | ザ プロクター アンド ギャンブル カンパニー | 亜鉛イオノフォア性を有する物質の使用 |
US20050202984A1 (en) * | 2003-03-18 | 2005-09-15 | Schwartz James R. | Composition comprising zinc-containing layered material with a high relative zinc lability |
US9381148B2 (en) * | 2003-03-18 | 2016-07-05 | The Procter & Gamble Company | Composition comprising particulate zinc material with a high relative zinc lability |
JP5334575B2 (ja) * | 2005-05-25 | 2013-11-06 | ローラス セラピューティクス インコーポレーテッド | 2−インドリルイミダゾ[4,5‐d]フェナントロリン派生物および癌治療におけるそれらの使用 |
EP2632470B1 (en) * | 2010-10-28 | 2018-02-28 | The Procter and Gamble Company | Personal care compositions comprising a pyrithione and an iron chelator |
-
2011
- 2011-10-28 EP EP11782318.7A patent/EP2632552B1/en active Active
- 2011-10-28 CN CN201510541075.5A patent/CN105168225A/zh active Pending
- 2011-10-28 CN CN2011800500030A patent/CN103167894A/zh active Pending
- 2011-10-28 WO PCT/US2011/058269 patent/WO2012058526A1/en active Application Filing
- 2011-10-28 JP JP2013536864A patent/JP2013543847A/ja active Pending
- 2011-10-28 MX MX2013004556A patent/MX361964B/es active IP Right Grant
- 2011-10-28 BR BR112013008578-9A patent/BR112013008578B1/pt active IP Right Grant
-
2015
- 2015-08-18 JP JP2015160847A patent/JP2016006105A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2016006105A (ja) | 2016-01-14 |
JP2013543847A (ja) | 2013-12-09 |
EP2632552A1 (en) | 2013-09-04 |
WO2012058526A1 (en) | 2012-05-03 |
MX2013004556A (es) | 2013-06-07 |
BR112013008578B1 (pt) | 2020-11-03 |
CN103167894A (zh) | 2013-06-19 |
CN105168225A (zh) | 2015-12-23 |
BR112013008578A2 (pt) | 2016-07-12 |
EP2632552B1 (en) | 2019-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019010602A (es) | Inhibidores de cdk. | |
TR201901930T4 (tr) | Topraktaki mikrobiyal aktivitenin geliştirilmesine yönelik bir yöntem. | |
IN2014CN02887A (es) | ||
NZ607600A (en) | Compositions for the treatment of diseases | |
EP3354640A3 (en) | Mif inhibitors and their uses | |
TN2012000543A1 (en) | Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application | |
MX342951B (es) | Composiciones terapeuticamente activas y su metodo de uso. | |
EA201201648A1 (ru) | Стимуляторы sgc | |
MX2013008212A (es) | Derivados de 7-azaindol. | |
MX2011011735A (es) | Compuestos y metodos para la inhibicion de renina, e indicaciones para ello. | |
MX336381B (es) | Boronatos como inhibidores de arginasa. | |
JO3450B1 (ar) | أشكال جرعات تحرير جديدة معدلة لمثبطات زانثين اوكسيدوريدوكتيز أو مثبطات زانثين اوكسيديز | |
MX2021005494A (es) | Composicion farmaceutica que comprende un derivado de amida que inhibe el crecimiento de celulas con cancer y lubricante de sal no metalica. | |
IN2014KN01235A (en) | Combinations of antifungal compounds and tea tree oil | |
MX2015012452A (es) | Inhibición o reducción del crecimiento de hongos. | |
WO2013059582A3 (en) | Small molecule inhibitors of histone deacteylases | |
MY168539A (en) | Catechol o-methyltransferase activity inhibiting compounds | |
EA024194B8 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
MX338980B (es) | Metodos de tratamiento utilizando inhibidores de tlr7 y/o tlr9. | |
WO2013023084A3 (en) | Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells | |
MY164015A (en) | Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof | |
MX2011011229A (es) | Metodo para reducir la presion intraocular en los seres humanos. | |
NZ709411A (en) | New bacteria and consortia for the reduction of amonia and/or methane emission in manure or soil | |
GB2502462A (en) | Stem cell factor inhibitor | |
MX361964B (es) | Inhibición del crecimiento microbiano por inhibición de aconitasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |